“…We showed that one of the new genes, APRIN/Pds5B (formerly AS3), was involved in proliferative arrest in vitro (Geck et al, 2000) and in vivo (Maffini et al, 2002). APRIN is a candidate tumor suppressor, its role in cancer pathways, its genomic losses or downregulation were detected in a variety of cancers and cancer cell lines (Geck et al, 2001), including esophageal (Harada et al, 2001;Zhang et al, 2008), head and neck (Reis et al, 2005), cervical (Seo et al, 2005), prostate (Murthy et al, 2005) and others.…”